New modifications to the area of pyrazole-naphthyl urea based p38 MAP kinase inhibitors that bind to the adenine/ATP site.

Moss, Neil; Breitfelder, Steffen; Betageri, Raj; Cirillo, Pier F; Fadra, Tazmeen; Hickey, Eugene R; Kirrane, Thomas; Kroe, Rachel R; Madwed, Jeffrey; Nelson, Richard M; Pargellis, Christopher A; Qian, Kevin C; Regan, John; Swinamer, Alan; Torcellini, Carol

Moss, Neil; Breitfelder, Steffen; Betageri, Raj; Cirillo, Pier F; Fadra, Tazmeen; Hickey, Eugene R; Kirrane, Thomas; Kroe, Rachel R; Madwed, Jeffrey; Nelson, Richard M; Pargellis, Christopher A; Qian, Kevin C; Regan, John; Swinamer, Alan; Torcellini, Carol.

Affiliation

Moss N; Department of Medicinal Chemistry, Boehringer Ingelheim Pharmaceutical, Inc., 900 Ridgebury Road, Ridgefield, CT 0687, USA. nmoss@rdg.boehringeringleheim.com

Bioorg Med Chem Lett ; 17(15): 4242-7, 2007 Aug 01.

Article in En | MEDLINE | ID: mdl-17560108

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Adenine / P38 Mitogen-Activated Protein Kinases / Protein Kinase Inhibitors Limits: Humans Language: En Journal: Bioorg Med Chem Lett Journal subject: BIOQUIMICA / QUIMICA Year: 2007 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido

Search on Google

Add to My VHL

XML

PubMed Links